Dostimine Tablet

Uses:

• Myasthenia Gravis: Primarily used to treat muscle weakness in myasthenia gravis, an autoimmune condition affecting neuromuscular junctions. It helps improve muscle strength but does not cure the condition.
• Paralytic Ileus: Treats intestinal atony (constipation due to muscle inactivity).
• Post-Operative Urinary Retention: Assists with difficulty in passing urine after surgery.
• Reversal of Non-Depolarizing Muscle Relaxants: Used intravenously to reverse the effects of non-depolarizing neuromuscular blockers post-surgery.
• Other Uses: May be used in military settings as a prophylactic against nerve gas exposure or for conditions like postural orthostatic tachycardia syndrome (POTS) to improve orthostatic symptoms.

Dosage:

• Myasthenia Gravis:
  • Adults: Typically 600 mg/day (10 tablets of 60 mg), spaced to provide maximum relief. Mild cases may require 60–360 mg/day (1–6 tablets), while severe cases may need up to 1,500 mg/day (25 tablets). Doses are adjusted based on individual response.
  • Children: Initial dose for under 6 years is 30 mg (½ tablet); for 6–12 years, 60 mg (1 tablet). Dosage is increased gradually (15–30 mg daily) until optimal effect, usually 30–360 mg/day.
• Paralytic Ileus/Post-Operative Urinary Retention:
  • Adults: 60–240 mg/day (1–4 tablets).
  • Children: 15–60 mg/day (¼–1 tablet).
• Doses are typically taken with water, 30–60 minutes before meals or when muscle strength is needed most. Tablets can be broken for easier swallowing.

Administration:

• Take with food or milk to reduce stomach upset.
• Swallow whole; do not crush or chew if using extended-release formulations.
• Dosage timing is critical for myasthenia gravis, often requiring a daily record of dose timing and effects to optimize treatment.

Contraindications:

• Mechanical intestinal or urinary obstruction.
• Known hypersensitivity to pyridostigmine, bromides, or any tablet ingredients.
• Use with caution in patients with bronchial asthma, COPD, arrhythmias, bradycardia, vagotonia, kidney disease, or Parkinson’s disease.

Side Effects:

• Common (Muscarinic): Nausea, vomiting, diarrhea, abdominal cramps, increased salivation, increased bronchial secretions, sweating, miosis (pupil constriction).
• Nicotinic: Muscle cramps, twitching, weakness.
• Other: Blurred vision, dizziness, headaches, urinary urgency, skin rash (due to bromide content).
• Serious: Cholinergic crisis (overdose) with worsening muscle weakness, breathing difficulties, or paralysis. Seek immediate medical help if suspected.

Precautions:

• Cholinergic Crisis vs. Myasthenic Crisis: Overdosage can lead to cholinergic crisis (severe muscle weakness, respiratory failure), which mimics myasthenic crisis (disease worsening). Differentiation may require a Tensilon (edrophonium) test and clinical judgment. Cholinergic crisis requires stopping the drug and administering atropine; myasthenic crisis may need increased doses.
• Pregnancy/Breastfeeding: Use only if benefits outweigh risks. Pyridostigmine crosses the placenta and may pass into breast milk in small amounts. Monitor newborns for effects.
• Driving/Operating Machinery: May cause drowsiness or blurred vision; avoid activities requiring alertness until effects are known.
• Kidney Impairment: Lower doses may be needed as pyridostigmine is excreted unchanged by the kidneys.

Interactions:

• Drugs: May interact with atropine, belladonna, clidinium, dicyclomine, glycopyrrolate, hyoscyamine, aminoglycosides, antiarrhythmics, or corticosteroids. Methylcellulose can inhibit absorption.
• Alcohol: May increase drowsiness; avoid consumption.
• Inform your doctor of all medications, supplements, or herbal products.

Storage:

• Store at room temperature (15–30°C or 59–86°F) in a dry place, preferably with silica gel due to hygroscopic nature. Keep out of reach of children.